Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1999
10/12/1999US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965583 Substituted imidazoles useful in the treatment of inflammatory disease
10/12/1999US5965582 Antihistamines
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965544 Synthetic multivalent sLex containing polylactosamines and methods for use
10/12/1999US5965540 Antiinflammatory agent
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965166 Dry shearing a mixture of 60-95% acetaminophen and a direct compression vehicle, microcrystalline cellulose, into a stable homogenous granulate; mixing with a lubricant and compressing into a solid dose
10/12/1999US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999CA1340785C Platelet activating factor antagonists
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999WO1999050285A2 Production methods and uses of a retrovirus
10/07/1999WO1999050282A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999WO1999050252A2 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049883A2 Oxidized thymosin beta 4
10/07/1999WO1999049874A1 Dextran formulations and method for treatment of inflammatory joint disorders
10/07/1999WO1999049867A1 Novel galenic formulations of meloxicam for oral administration
10/07/1999WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999WO1999049845A1 Peroral active agent suspension
10/07/1999WO1999027924A3 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
10/07/1999DE19814963A1 MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie MAPKAP kinase 2 inhibitors and their use for the anti-inflammatory therapy
10/07/1999CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999CA2325984A1 Oxidized thymosin beta 4
10/07/1999CA2324584A1 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same
10/07/1999CA2324511A1 Novel peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/06/1999EP0947584A1 Loxoprofen-containing preparation for external use
10/06/1999EP0947524A1 Novel peptides for the treatment of autoimmune diseases
10/06/1999EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999EP0946725A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946596A1 Peptide derivatives
10/06/1999EP0946589A1 Inhibitors of peptide binding to mhc class ii proteins
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946568A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946548A1 Novel heterocyclic substituted pyrrolidine amide derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946523A1 Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946511A1 Novel compounds with analgesic effect
10/06/1999EP0946510A1 Novel compounds with analgesic effect
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946182A1 17$g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
10/06/1999EP0946164A1 Integrin antagonists
10/06/1999EP0946163A2 Salts of acetaminophen
10/06/1999EP0946156A2 Therapeutic agents
10/06/1999CN1230955A Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
10/05/1999US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999US5962698 Plasminogen activator inhibitor
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962532 Therapeutic method with capsaicin and capsaicin analogues
10/05/1999US5962531 5-aroylnaphthalene derivatives as anti-inflammatory agents
10/05/1999US5962529 Metalloproteinase inhibitors
10/05/1999US5962492 Antiasthma agents; antiinflammatory agents
10/05/1999US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999US5962485 N-(2-benzyloxy-1-phenethyl)-N-(2'-methoxyethyl)amino-methane compounds are useful as tachykinin antagonists
10/05/1999US5962483 Antiasthma agents; antiinflammatory agents
10/05/1999US5962479 Psychological and nervous sytem disorders
10/05/1999US5962449 Analgesics; antiinflammatory agents; non-insulin-dependentdiabetes
10/05/1999US5962422 Inhibition of selectin binding
10/05/1999US5962265 A polypeptide is described which is expressed at a particularly high level in tissues of the human immune system.
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
10/05/1999US5960792 Device for aerosolized delivery of peptide drugs
10/05/1999CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
10/05/1999CA2009902C Heterocycles
09/1999
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999049018A1 Glycosyl sulfotransferase-3
09/30/1999WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease
09/30/1999WO1999048881A1 Metalloproteinase inhibitors
09/30/1999WO1999048879A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins
09/30/1999WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm)
09/30/1999WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999WO1999048492A1 Amide derivatives and nociceptin antagonists
09/30/1999WO1999048361A1 Xylitol compositions for treating upper respiratory conditions
09/30/1999WO1999038877A3 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
09/30/1999WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis
09/30/1999WO1999035266A3 Human urotensin ii
09/30/1999WO1999032449A3 Benzazine derivatives as phosphodiesterase 4 inhibitors
09/30/1999WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase
09/30/1999CA2325638A1 Amide derivatives and nociceptin antagonists
09/30/1999CA2325585A1 Inflammatory mediator antagonists
09/30/1999CA2324347A1 Benzoates derivatives for inhibiting angiogenesis
1 ... 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 ... 1272